Pulse Biosciences, Inc. (PLSE) |
|
4.18 0.1 (2.45%)
|
09-26 15:12 |
|
Open: |
4.13 |
Pre. Close: |
4.08 |
|
High:
|
4.34 |
Low:
|
4.03 |
|
Volume:
|
70,277 |
Market Cap:
|
229(M) |
|
|
|
Technical analysis |
as of: 2023-09-26 2:51:32 PM |
|
Short-term rate:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 7.9  One year: 9.88 |
| Support: |
Support1: 4.03 Support2: 3.35 |
| Resistance: |
Resistance1: 6.77 Resistance2: 8.46 |
| Pivot: |
4.46 |
| Moving Average: |
MA(5): 4.17 MA(20): 4.56
MA(100): 6.52 MA(250): 4.43  |
| MACD: |
MACD(12,26): -0.7 Signal(9): -0.7 |
| Stochastic oscillator: |
%K(14,3): 11.6 %D(3): 9.5 |
| RSI: |
RSI(14): 30.8 |
| 52-week: |
High: 9.68 Low: 1.57 |
| Average Vol(K): |
3-Month: 182 (K) 10-Days: 134 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PLSE ] has closed above bottom band by 17.4%. Bollinger Bands are 59.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.45 - 4.48 |
4.48 - 4.5 |
|
Low:
|
4 - 4.03 |
4.03 - 4.05 |
|
Close:
|
4.03 - 4.07 |
4.07 - 4.11 |
|
Company Description |
|
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California. |
Headline News |
Sat, 23 Sep 2023
Pulse Biosciences, Inc. (NASDAQ:PLSE) Holdings Cut by Westside ... - MarketBeat
Mon, 18 Sep 2023
Is Pulse Biosciences Inc (PLSE) Stock Worth a Buy Monday? - InvestorsObserver
Thu, 07 Sep 2023
Pulse Biosciences to Present at Gilmartin Group Emerging Growth ... - Business Wire
Wed, 30 Aug 2023
Is Pulse Biosciences Inc (PLSE) a Smart Choice in Medical Instruments & Supplies Wednesday? - InvestorsObserver
Tue, 29 Aug 2023
Healthcare Stocks Making Moves Tuesday: ICCT, TIVC, TSHA, NPCE, CAPR, PLSE, OTRK, EBS - InvestorsObserver
Wed, 23 Aug 2023
How Will the Market React to Pulse Biosciences Inc (PLSE) Stock Getting a Bearish Rating - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Instruments & Supplies |
| Shares Out. |
0 (M) |
| Shares Float |
55 (M) |
|
% Held by Insiders
|
1.724e+007 (%) |
|
% Held by Institutions
|
99.8 (%) |
|
Shares Short
|
1,700 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-4.528e+007 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
517 |
|
Return on Assets (ttm)
|
322.2 |
|
Return on Equity (ttm)
|
-50.5 |
|
Qtrly Rev. Growth
|
-9000 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
-88.81 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
-1.2 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-34 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
-0.05 |
|
Price to Cash Flow
|
4.72 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
1.88e+006 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
